BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00621361-completion@plaintrial.com
DTSTAMP:20261029T233846Z
DTSTART;VALUE=DATE:201202
SUMMARY:Phase I Safety and Tolerability Study of Cediranib (RECENTIN™\, A
 ZD2171) in Combination With Chemo in First Line Lung Cancer Patients — e
 stimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT00621361
URL:https://plaintrial.com/trial/NCT00621361
END:VEVENT
END:VCALENDAR